Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.

OBJECTIVES: To enable better monitoring of interim outcome measures in the NHS Breast Screening Programme by providing revised targets for cancer detection rates, and revised expected interval cancer rates. DESIGN AND SETTING: Expected detection rates of invasive cancers at prevalent screen are calculated, using estimates of the underlying England and Wales incidence rates and age specific prevalence incidence ratios from the Swedish Two County Study. Expected interval cancer rates are also derived from this study, and are used to calculate expected detection rates at rescreening. RESULTS: The expected invasive cancer detection rates at first screen for women aged 50-52 is 3.6 per 1000. The expected rate at rescreening for women aged 53-64 is 4.0 per 1000. Expected interval cancer rates for women screened from 1995/6 onwards are 0.45 per 1000, 0.65 per 1000, and 1.2-1.3 per 1000 for the periods within 0-<12, 12-<24, and 24-<36 months of screening. CONCLUSIONS: The target cancer detection rates and expected interval cancer rates for the NHS Breast Screening Programme have been revised in the light of more recent data. Monitoring of the extent to which the programme is meeting these revised targets will give a more accurate indication of the potential to meet the Health of the Nation target of a 25% reduction in breast cancer mortality by the year 2000.

[1]  Uktrialofearlydetectionofbre FIRST RESULTS ON MORTALITY REDUCTION IN THE UK TRIAL OF EARLY DETECTION OF BREAST CANCER , 1988 .

[2]  A. Threlfall,et al.  Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region , 1995, BMJ.

[3]  Description of method Trial of early detection of breast cancer: description of method. , 1981, British Journal of Cancer.

[4]  L. Tabár,et al.  Breast screening, prognostic factors and survival--results from the Swedish two county study. , 1991, British Journal of Cancer.

[5]  C. Camilleri-Ferrante,et al.  Monitoring Interval Cancers in Breast Screening Programmes: The East Anglian Experience , 1995, Journal of medical screening.

[6]  A. Threlfall,et al.  Reliability of Underlying Incidence Rates for Estimating the Effect and Efficiency of Screening for Breast Cancer , 1996, Journal of medical screening.

[7]  L. Tabár,et al.  What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. , 1987, British Journal of Cancer.

[8]  D. Ikeda,et al.  Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations. , 1992, AJR. American journal of roentgenology.

[9]  N. Wald,et al.  UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening , 1995, BMJ.

[10]  R. Blanks,et al.  Monitoring the Performance of Breast Screening Programmes: Allowing for Geographical Variation in Breast Cancer Incidence , 1996, Journal of medical screening.

[11]  N. Day,et al.  Breast cancer screening programmes: the development of a monitoring and evaluation system. , 1989, British Journal of Cancer.

[12]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[13]  N. Day,et al.  Monitoring the Performance of Breast Screening Programmes: Use of Indirect Standardisation in Evaluating the Invasive Cancer Detection Rate , 1996, Journal of Medical Screening.

[14]  R. Blanks,et al.  Results from the NHS Breast Screening Programme 1990–1993 , 1995, Journal of medical screening.